Status:

NOT_YET_RECRUITING

Pulmonary Deposition of Ultrasound Rock Salt Aerosol Inhalation Therapy

Lead Sponsor:

Jingen Xia

Conditions:

COPD

Asthma Bronchiale

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

In the in vitro modeling phase, the investigators plan to use a realistic human upper respiratory tract model and an asymmetric ideal bronchial tree model. By combining 3D printing experiments with CF...

Detailed Description

I. Research Background Respiratory diseases, such as asthma, COPD, cystic fibrosis and other chronic respiratory inflammatory diseases, are major global health problems. WHO data shows respiratory dis...

Eligibility Criteria

Inclusion

  • Healthy volunteers; Patients with chronic airway disease requiring nebulization therapy.

Exclusion

  • Those aged \< 18 years; Refusing to participate in the study; Patients requiring invasive ventilator assisted breathing; Patients with artificial airways. Patients with chronic liver and kidney function injury. Allergic to radioactive elements.

Key Trial Info

Start Date :

March 31 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2026

Estimated Enrollment :

26 Patients enrolled

Trial Details

Trial ID

NCT06891274

Start Date

March 31 2025

End Date

March 31 2026

Last Update

March 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

China-Japan Friendship Hospital

Beijing, China

Pulmonary Deposition of Ultrasound Rock Salt Aerosol Inhalation Therapy | DecenTrialz